Christopher Mims in the Wall Street Journal (WSJ) writes about how, after more than a half-century of making microchips in more or less the same way, profound changes are coming. Mims talks about how the Cardea Bio graphene-based “biology-gated transistor” will be part of this revolution.

Read the full article here: Wall Street Journal

This post was originally published at Cardea Bio was acquired by Paragraf on 2 May 2023.

Join our mailing list